Dana Goldman, PhD
Articles
Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation
Limiting access to non–vitamin K antagonist oral anticoagulants through step therapy and prior authorization may exacerbate current underuse of anticoagulants and increase the risk of stroke in patients with newly diagnosed atrial fibrillation.
The Long-term Social Value of Granulocyte Colony-Stimulating Factors
Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Medicaid Prior Authorization Policies and Imprisonment Among Patients With Schizophrenia
This study examined the impact of prior authorization formularies on the likelihood that patients with schizophrenia will be arrested and incarcerated.
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis
This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.
Bending the Curve Through Health Reform Implementation
Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Bending the Curve: Effective Steps to Address Long-Term Healthcare Spending Growth
A group of experts who have spent their careers studying the healthcare system have convened to identify a path for sustainable reform in healthcare cost growth.
